Jefferies Financial Group reiterated their buy rating on shares of Bridgepoint Group (LON:BPT – Free Report) in a report published on Tuesday morning, MarketBeat Ratings reports. They currently have a GBX 310 ($3.97) target price on the stock.
Separately, JPMorgan Chase & Co. decreased their price target on Bridgepoint Group from GBX 262 ($3.36) to GBX 259 ($3.32) and set a neutral rating for the company in a research note on Wednesday, April 3rd.
Read Our Latest Report on Bridgepoint Group
Bridgepoint Group Trading Up 1.9 %
Bridgepoint Group Company Profile
Bridgepoint Group plc is private equity and private credit firm specializing in middle market, lower mid cap, small cap, growth capital and buyouts investment. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Featured Stories
- Five stocks we like better than Bridgepoint Group
- Dividend Capture Strategy: What You Need to Know
- Sales Breakout Sends This Semiconductor Stock to Record High
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Surprise Buying Opportunity on This Dividend Aristocrat
- About the Markup Calculator
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.